Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists
- PMID: 2105329
- DOI: 10.1210/jcem-70-2-328
Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists
Abstract
To examine the differential regulation of glycoprotein hormone secretion from the gonadotrope by GnRH, the Nal-Glu GnRH antagonist was administered to euthyroid women in the early follicular phase (days 1-5) of the menstrual cycle, and the results compared to previous studies with the Nal-Arg GnRH antagonist. After a 4-h period of baseline sampling at a frequency of every 10 min, a single sc dose of the GnRH antagonist was administered to each subject. Frequent sampling continued for 8 h, followed by hourly sampling for a further 16 h. LH, FSH, and free alpha-subunit were measured serially in assays with high specificity. There was a 90% concordance of LH and free alpha-subunit pulses during the baseline sampling period. Pulsatile secretion of LH and free alpha-subunit was immediately abolished at the highest dose of the Nal-Glu antagonist for at least 8 h. The maximum percent suppression of LH after administration of the Nal-Glu GnRH antagonist was 70 +/- 4%, 80 +/- 4%, and 83 +/- 1% at doses of 15, 50, and 150 micrograms/kg, respectively, compared to 51 +/- 10%, 70 +/- 5%, and 69 +/- 5% at doses of 50, 150, and 500 micrograms/kg Nal-Arg antagonist. Decreases in FSH were 28 +/- 2%, 32 +/- 7%, and 39 +/- 2%, with increasing doses of the Nal-Glu antagonist compared with 25 +/- 6%, 17 +/- 6%, and 28 +/- 4% reductions at increasing doses of the Nal-Arg antagonist. Free alpha-subunit decreased 22 +/- 4%, 23 +/- 4%, and 28 +/- 3% at increasing doses of the Nal-Glu antagonist and 12 +/- 4%, 27 +/- 4%, and 30 +/- 7% with increasing doses of the Nal-Arg antagonist. For the Nal-Glu antagonist, suppression of LH was greater than that of FSH and free alpha-subunit at all doses (P less than 0.001), while FSH suppression was greater than that of free alpha-subunit at the highest dose only (P less than 0.05). For the Nal-Arg antagonist, LH suppression was greater than that of FSH or free alpha-subunit at all doses (P greater than 0.01), and FSH suppression exceeded that of free alpha-subunit at the 50 micrograms/kg dose. Suppression of LH was greater with the Nal-Glu antagonist than with the Nal-Arg antagonist at doses of 50 and 150 micrograms/kg (P less than 0.05), and FSH suppression was greater with the Nal-Glu antagonist at 150 micrograms/kg (P less than 0.01), while the degrees of maximum suppression were similar for the two different GnRH antagonists for free alpha-subunit.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist.J Clin Endocrinol Metab. 1988 Sep;67(3):524-31. doi: 10.1210/jcem-67-3-524. J Clin Endocrinol Metab. 1988. PMID: 3137243
-
Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.J Clin Endocrinol Metab. 1990 May;70(5):1472-8. doi: 10.1210/jcem-70-5-1472. J Clin Endocrinol Metab. 1990. PMID: 2110578
-
Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.J Clin Endocrinol Metab. 1994 Feb;78(2):343-7. doi: 10.1210/jcem.78.2.8106622. J Clin Endocrinol Metab. 1994. PMID: 8106622
-
Inhibition of ovulation: comparison between the mechanism of action of steroids and GnRH analogues.Hum Reprod. 1988 May;3(4):503-6. doi: 10.1093/oxfordjournals.humrep.a136735. Hum Reprod. 1988. PMID: 3292571 Review.
-
[Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders].Ned Tijdschr Geneeskd. 2000 Feb 19;144(8):370-4. Ned Tijdschr Geneeskd. 2000. PMID: 10703589 Review. Dutch.
Cited by
-
Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.Front Endocrinol (Lausanne). 2021 Sep 13;12:705264. doi: 10.3389/fendo.2021.705264. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34589055 Free PMC article.
-
Absence of circadian rhythms of gonadotropin secretion in women.J Clin Endocrinol Metab. 2011 May;96(5):1456-61. doi: 10.1210/jc.2010-2739. Epub 2011 Feb 23. J Clin Endocrinol Metab. 2011. PMID: 21346063 Free PMC article.
-
Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6894-8. doi: 10.1073/pnas.91.15.6894. Proc Natl Acad Sci U S A. 1994. PMID: 8041716 Free PMC article.
-
Reproductive hormone genes in mothers of spontaneous dizygotic twins: an association study.Hum Genet. 1993 Mar;91(2):118-20. doi: 10.1007/BF00222710. Hum Genet. 1993. PMID: 8096491
-
Modeling associations between latent event processes governing time series of pulsing hormones.Biometrics. 2018 Jun;74(2):714-724. doi: 10.1111/biom.12790. Epub 2017 Oct 31. Biometrics. 2018. PMID: 29088494 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical